Esaote Introduces MyLab™X8, High-performance and Versatile Platform to Further Expand the Renewed MyLab™ Ultrasound Product Line
VIENNA, Feb. 27, 2019 /PRNewswire/ -- Esaote announces the launch of the MyLab™X8 - the high-performance and versatile ultrasound platform to support hospitals and clinics facing today's challenges - at the European Congress of Radiology, ECR 2019 at booth number X5/510.
Based on the recently introduced ULTRA™ technology platform, the product profile includes a limitless approach to ultrasound imaging and high-quality patient care.
"The new MyLab™X8 is designed to be a reliable partner in the daily clinical routine," said Luca Bombino, Head of Ultrasound Global Marketing at Esaote. "We leveraged scalable technology to completely renew our ultrasound product line, and migrate premium performance and features to more affordable systems, without compromising clinical confidence, throughput, and reliability."
Esaote has always invested in workflow-oriented design. The MyLab™9, its flagship ultrasound product, has many solutions in common with the new MyLab™X8, including the control panel design and exam time reduction and automation.
easyMode* and easyColor* are two exclusive Esaote solutions which simplify and drive ultrasound image optimization in just 3 swipes.
The new "Never Stop Seeing the Unseen" ad campaign will be unveiled during ECR 2019 to highlight Esaote's attitude to innovation, research, and development, affirming the Italian company as one of the world's leading providers of diagnostic imaging solutions.
The MyLab™X8 and the MyLab™ ultrasound product line include a wide range of cutting-edge technologies, such as:
- Virtual Navigator fusion imaging
- QElaXto shearwave elastography
- Very high-frequency, microV, QPack
- Exam automation tools like eScan, eDoppler, zero-click advanced functions
* patent pending
MyLab is a trademark of Esaote spa.
Technology and features are system/configuration dependent. Specifications are subject to change without notice. Information might refer to products or modalities not yet approved in all countries. For further details, please contact your Esaote sales representative.
With a consolidated revenue of about EUR 250 million in 2017, Esaote is a leader in the biomedical equipment sector, in particular in the areas of ultrasound, dedicated MRI, and software for managing the diagnostic process. The company currently employs 1,150 people. With its headquarters in Genoa and its own production and research units in Italy and the Netherlands, Esaote is active in 80 countries in the world.